@article{ATM24691,
author = {Louis-Charles Desbiens and Fabrice Mac-Way},
title = {Does alfacalcidol reduce cardiovascular complications in hemodialysis patients?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {8},
year = {2019},
keywords = {},
abstract = {Cardiovascular disease is a major health burden in chronic kidney disease (CKD) populations. Indeed, individuals with end-stage renal disease (ESRD) have a 6 to 8-fold increase in mortality compared to the general population, half of which is caused by cardiovascular disease (1). The mineral and bone disorder of CKD (CKD-MBD), which also includes vascular calcification, contributes to these cardiovascular complications (2).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24691}
}